Adenylate cyclase (AC) toxin from Bordetella pertussis is unusual in that, unlike most other members of the repeats-in-toxin family that are released into the extracellular milieu, it remains associated with the bacterial surface. In this study, we investigated the nature of the association of this toxin with the surface of B. pertussis . AC toxin was extracted from crude outer membrane preparations of B. pertussis with 8 M urea, but only partially with alkaline sodium carbonate and not at all with octylglucoside, suggesting that denaturation of the toxin is necessary for its removal from the membrane. B. pertussis mutants lacking filamentous haemagglutinin (FHA) released significantly more AC toxin into the medium, and AC toxin association with the bacterial surface was partially restored by expression of FHA from a plasmid, suggesting a role for FHA in surface retention of AC toxin. AC toxin distribution was unaffected by the absence of pertactin, or full-length lipopolysaccharide, or a defect in secretion of pertussis toxin. Using overlay and immunoprecipitation, we found that a direct physical association can occur between AC toxin and FHA. Combined, these findings suggest that FHA may play a role in AC toxin retention on the surface of B. pertussis and raise the possibility of an involvement of adherence mediated by FHA in delivery of AC toxin from the bacterium to the target cell.
Introduction
Bordetella pertussis , the causative agent of whooping cough, has re-emerged as an important pathogen among young children and adults throughout the world (Hewlett, 1999) . B. pertussis produces a number of proteins essential to its virulence, including adenylate cyclase (AC) toxin, filamentous haemagglutinin (FHA), pertactin (PRN), pertussis toxin (PTX) and fimbriae (FIM) (Locht, 1999) . AC toxin is a unique member of the repeats-in-toxin (RTX) family of bacterial toxins (Welch, 1991; Coote, 1992; Ludwig and Goebel, 1999) , which includes Escherichia coli haemolysin and leukotoxins from Pasteurella haemolytica and Actinobacillus actinomycetemcomitans . These proteins are characterized by the presence of glycine/aspartate-rich nonameric repeats.
Adenylate cyclase toxin is unique because, unlike other RTX family members, it contains two functionally separable domains, one of which possesses AC enzymatic activity and the second, which haemolyses red blood cells (Glaser et al ., 1988; Hanski, 1989; Ehrmann et al ., 1991; Ladant and Ullmann, 1999) . After translocation into a target cell, the AC domain is activated by host cell calmodulin and catalyses the uncontrolled production of intracellular cAMP from ATP, a process termed intoxication (Hanski, 1989; Ehrmann et al ., 1991; Gray et al ., 1998) . Supraphysiological levels of cAMP suppress leukocyte functions such as chemotaxis, phagocytosis and oxidative burst, potentiating B. pertussis survival (Confer and Eaton, 1982; Hanski and Farfel, 1985; Friedman et al ., 1987; Pearson et al ., 1987) .
Like other RTX toxins, of which the most extensively studied is E. coli haemolysin, AC toxin is secreted by a type I secretion apparatus that in B. pertussis is encoded by cyaB , cyaD and cyaE , which are arranged in an operon with the AC toxin structural gene, cyaA (Glaser et al ., 1988) . Whereas E. coli haemolysin is released into the extracellular medium (Ludwig and Goebel, 1999) , B. pertussis AC toxin is not, with the majority of the toxin remaining associated with the bacterial surface (Hewlett et al ., 1976) . A. actinomycetemcomitans leukotoxin also remains associated with intact organisms (Tsai et al ., 1984) , an interaction that appears to be mediated by binding to nucleic acids on the surface of the bacterium (Ohta et al ., 1993) .
Although secretion of E. coli haemolysin and B. pertussis AC toxin is presumed to occur by the same mechanism, it is unclear why haemolysin is primarily present in the medium of E. coli whereas AC toxin remains associated with the bacterium, with only a small proportion of the toxin released into the supernate. One possibility is that outer membrane proteins of B. pertussis , such as FHA and PRN, which are involved in adherence to host cells (Urisu et al ., 1985; 1986; Relman et al ., 1989; Leininger et al ., 1991) , influence the association of AC toxin with the bacterial surface. Recently, Kachlany and co-workers reported that in A. actinomycetemcomitans , expression of the tad operon that encodes long fibrils responsible for rough colony morphology and adherence to surfaces, is important for leukotoxin localization to the bacterial outer membrane (Kachlany et al ., 2000) . Supporting a role for FHA in AC toxin association with the surface of B. pertussis are the observations that FHAdeficient mutants release more AC toxin into the medium (Weiss et al ., 1983) and FHA co-purifies with AC toxin during some purification protocols (E. L. Hewlett, unpublished) . In addition, early studies indicated that PRN contained contaminating AC activity (Novotny et al ., 1985) . Combined, these findings suggest that AC toxin may associate with FHA and/or PRN, however, this hypothesis has never been directly tested.
The purpose of this study was to investigate the nature of the association of AC toxin with the surface of B. pertussis as a first step towards understanding how AC toxin is delivered from B. pertussis to target cells. We evaluated the ability of buffers and detergents to extract AC toxin from B. pertussis membrane preparations to determine whether AC toxin is a peripheral or integral membrane protein and to learn if AC toxin associates with the membrane by ionic interactions. To examine the role of outer membrane virulence determinants in the association of AC toxin with the surface of B. pertussis , we examined AC toxin distribution in a variety of B. pertussis mutants lacking expression of FHA, PRN, or full-length LPS, or defective for PTX secretion. Because results from these initial studies suggested an association between AC toxin and FHA, we further investigated this possibility by overlay and immunoprecipitation experiments. Results from these experiments suggest that a previously unrecognized physical association exists between AC toxin and FHA; this interaction may potentiate delivery of AC toxin during infection.
Results and discussion

Denaturation is required to remove AC toxin from B. pertussis outer membranes
Previous work has shown that AC toxin is extracytoplasmic, but remains primarily associated with, and exposed on the surface of B. pertussis (Hewlett et al ., 1976) . Whereas only 18% of AC enzymatic activity is measured in the supernate of exponentially growing B. pertussis organisms, the remaining 82% of AC enzymatic activity is associated with B. pertussis ; up to 93% of this activity is abolished after exposure of intact B. pertussis organisms to trypsin (Hewlett et al ., 1976) . These findings demonstrate that AC toxin is not only extracytoplasmic, but that the majority of the protein, at least the portion of it responsible for AC activity, is probably on the outer face of the outer membrane of B. pertussis .
Adenylate cyclase toxin contains a 200-amino-acid hydrophobic domain, but lacks amino acid sequence motifs consistent with b -sheet formation (Hanski, 1989) , a characteristic of known bacterial transmembrane outer membrane proteins (Tamm et al ., 2001) . Thus, it is likely that AC toxin associates with the outer membrane of B. pertussis in a fashion that does not include insertion, but rather by a mechanism that may involve ionic or hydrophobic interactions. To understand the nature of the interaction by which AC toxin remains associated with B. pertussis , we investigated the ability of various buffers and detergents to extract AC toxin from crude outer membrane preparations.
Total membranes (inner and outer) were prepared from B. pertussis and treated with Triton X-100. The insoluble fraction represents crude outer membranes (Schneider and Parker, 1982; Johnson and Burns, 1994) and contains the majority of AC toxin as determined by Western blot analysis (data not shown). Consistent with the inability of Triton X-100 to solubilize AC toxin, octylglucoside (a nonionic detergent in the same family as Triton X-100) did not extract AC toxin from crude outer membranes (Fig. 1) . In addition, neither the ionic detergent, deoxycholate, nor the zwitterionic detergent, CHAPS, extracted AC toxin (data not shown). In contrast, 8 M urea-TEE (Tricine/EDTA/ EGTA) almost completely extracted AC toxin into the soluble fraction (Fig. 1 ), whereas TEE alone had no effect. When crude outer membranes were exposed to sodium carbonate (100 mM, pH 11.5), which disrupts ionic interactions resulting in the removal of peripheral membrane proteins (Fujiki et al ., 1982) , a minute amount of full-length AC toxin was released into the soluble fraction (Fig. 1) . Thus, it is unlikely that AC toxin associates with the outer membrane of B. pertussis through an ionic interaction. The majority of the cell-associated toxin, however, is strongly bound, perhaps in a fashion involving the hydrophobic domain that can only be disrupted by denaturation of the toxin, as occurs upon treatment with urea.
Association of AC toxin with the B. pertussis surface is dependent on the presence of FHA One possible mechanism by which AC toxin remains associated with the bacterial surface is through an interaction with other outer membrane proteins. A number of past observations provide a basis for this hypothesis. It has been reported that more AC toxin is released into the supernate of FHA-deficient B. pertussis organisms than WT (Weiss et al ., 1983) . FHA co-purifies with AC toxin and AC toxin may contaminate PRN preparations. Because previous studies analysing AC toxin distribution utilized FHA mutants with transposon insertions in the fhaA accessory gene (Weiss et al ., 1983; Locht et al ., 1993) , we asked whether a similar amount of AC toxin is released into the supernate of a B. pertussis mutant containing an in-frame, non-polar deletion of the FHA structural gene, fhaB (Locht et al ., 1992) .
Consistent with previous reports, greater than 90% of the total AC enzymatic activity was associated with the surface of wild-type B. pertussis (BP338) compared with less than 17% on the surface of an FHA transposon mutant (BP353) (p < 0.0001; Fig. 2 and Table 1) (Weiss et al ., 1983) . Similarly, much more of the total AC enzymatic activity (90%) was associated with the surface of a different wild type strain (BPSM) than its isogenic fhaB deletion mutant, BPGR4 (14.1%; p < 0.0001; Fig. 2 and Table 1 ). On the other hand, the distribution of FHA was not altered in an AC toxin-deficient B. pertussis mutant (BP348) as determined by Western blot analysis (data not shown). These data suggest that the presence of FHA is a major determinant in AC toxin association with the surface of B. pertussis but that the absence of AC toxin does not effect FHA localization.
We added soluble, purified AC toxin to BPSM or BPGR4 to determine if the presence or absence of FHA affects the ability of exogenously added, purified AC toxin to adhere to the bacterial surface. In three independent experiments, BPSM bound 3.3 ± 0.33-fold (mean ± SEM) more exogenous AC toxin than BPGR4, providing further evidence that AC toxin may associate with FHA on the surface of B. pertussis . Some exogenously added AC toxin did, however, bind to BPGR4, suggesting that FHA is not absolutely required for this type of association. The interaction of AC toxin with BPGR4 is probably due, at least in part, to the fact that this strain contains some AC toxin on its surface to which exogenous AC toxin may bind. This notion is supported by the finding that AC toxin binds less well to an AC toxin-negative B. pertussis mutant (F.R. Zaretzky, M.C. Gray, T. Kim and E.L. Hewlett, manuscript in preparation) and that AC toxin forms dimers in solution (S. J. Lee, M.C. Gray and E.L. Hewlett, manuscript in preparation) and binds to itself on blots (see below).
Defect in surface retention of AC toxin in BPGR4 can be complemented by expression of FHA
One way to establish a role for FHA in AC toxin retention on the surface of B. pertussis would be to demonstrate that expression of FHA in the FHA-deficient mutant restores the cell-surface association of AC toxin. We used BPGR4 harbouring a plasmid (pBG1) that contains a 10 kb Eco R1 fragment of fhaB minus the last 990 bp of the gene. Expression of FHA from pBG1 doubled the retention of AC toxin on the surface of BPGR4 (28% versus 14%; p = 0.037) but did not restore AC toxin association to wild-type levels ( Fig. 2 and Table 1 ). One possible explanation for this finding is that less FHA is expressed from pBG1 in BPGR4 than in the wild-type background; this possibility was supported by Western blot analysis (data not shown). Another possibility, although not mutually exclusive from the first, is that the truncated form of FhaB that is expressed from pBG1 (lacking the final 330 amino acids) has reduced ability to interact with AC toxin. To explore this possibility further, we Fig. 1 . Urea extracts adenylate cyclase (AC) toxin from Bordetella pertussis outer membranes. Crude outer membranes were prepared from B. pertussis (see Experimental procedures ) and 80 m g were incubated in 1 ml of either TEE (10 mM Tricine, 0.5 mM EDTA, 0.5 mM EGTA-pH 8.0), 8 M urea/TEE, 100 mM sodium carbonate (pH 11.5) or 10 mM octylglucoside/150 NaCl (pH 7.4) overnight at 4 ∞ C. The soluble fraction (S) was obtained after centrifugation of the membranes at 107 000 g for 1 h at 4 ∞ C. The insoluble fraction (I) was suspended in 1 ml of PBS, pH 7.5. Equal volumes of the soluble and insoluble fractions were subjected to SDS-PAGE and AC toxin was visualized by immunoblot analysis using a rabbit polyclonal antibody against AC toxin, followed by secondary HRP-conjugated anti-rabbit IgG and chemiluminescent detection. Fig. 2 . Association of AC enzymatic activity with B. pertussis organisms. B. pertussis strains were grown to mid-exponential phase, centrifuged at 6000 r.p.m. for 10 min, and the supernate and pellet (whole bacteria) were assayed in duplicate for AC enzymatic activity (see Experimental procedures ). Results are expressed as mean percent ± SEM of total (supernate + pellet) AC enzymatic activity present on the bacterial pellet and are from at least three independent bacterial cultures. used a construct (BPSA90) in which the 3¢-half of fhaB is deleted from the chromosome of BPSM; this strain produces an 82 kDa N-terminal FHA truncate (FHA44) (C. Locht, personal communication). More AC activity was associated with the surface of BPSA90 compared with BPGR4 ( Fig. 2 and Table 1), making it less likely that the C-terminal half of FHA is required for AC toxin interaction. However, significantly less AC toxin interacted with the surface of BPSA90 than with BPSM ( Fig. 2 and Tables 1, p = 0.044). This finding may be related to the amount of cell-associated FHA in B. pertussis expressing FHA44, which is reportedly less than wild type (RenauldMongenie et al., 1996) . These data support a role for FHA in AC toxin association with the bacterial surface and suggest that AC toxin may interact with the N-terminal 82 kDa portion of FHA.
Filamentous haemagglutinin is produced as a 367 kDa precursor protein (Domenighini et al., 1990; RenauldMongenie et al., 1996) that has been recently shown to be proteolytically processed by the SphB1 subtilisin-like protease into its 220 kDa mature form (Coutte et al., 2001) , which comprises the N-terminal 60% of the FHA precursor (Domenighini et al., 1990; Renauld-Mongenie et al., 1996) . A portion of the mature 220 kDa form of FHA is released into the extracellular medium, however, a significant proportion remains associated, or re-associates, with the surface of B. pertussis. The C-terminal portion of FHA has been proposed to act as a chaperone to prevent premature folding of the protein before its export to the cell surface, where it is subsequently processed (Domenighini et al., 1990; Renauld-Mongenie et al., 1996) .
Coutte and colleagues have recently reported that a B. pertussis mutant with deletion in sphB1 (BPLC5) is deficient for FHA processing and, as a result, the precursor 367 kDa protein is never cleaved and remains associated with the bacterium (Coutte et al., 2001) . We were interested in determining whether this mutant would have an altered distribution of AC enzymatic activity. The percentage of AC toxin activity released into the medium by BPLC5 was not significantly different from that released by the wild-type strain, BPSM (p = 0.088; Table 1 ).
AC toxin distribution is not dependent on other secreted B. pertussis virulence determinants
In light of the dramatic effect of FHA deficiency on AC toxin retention on the bacterial surface, we evaluated secreted virulence determinants for their effect on the association of AC toxin with B. pertussis. As shown in Table 1 , FHA was the only virulence determinant examined whose absence or alteration was associated with release of AC enzymatic activity into the supernate. Lack of PRN or full-length LPS, or impaired secretion of PTX, had no effect on AC toxin distribution. To be certain that the wild-type strains used in these studies (BP338, BPSM, BP536) are representative, we also examined AC toxin distribution in two recent clinical isolates of B. pertussis and the mouse challenge strain, 18323. Similar to wildtype laboratory strains, greater than 80% of AC enzymatic activity was bacteria-associated in both clinical isolates analysed, and in 18323 (Table 1) . During the course of this study, a number of mutants that had been constructed using a spontaneous streptomycin-resistant BP338 derivative (SM001) (Barry, 1985) were found to contain high percentages of AC enzymatic activity in the supernate (data not shown). In fact, these mutants were reported to lack FHA production by Western blot analysis (Barry, 1985) , thus explaining their reduced ability to retain AC toxin on their surface.
Overlay and immunoprecipitation demonstrate an interaction between AC toxin and FHA
Because our initial studies indicated that four to five times more AC toxin remains associated with the bacterial surface when FHA is produced, we asked whether purified AC toxin and FHA could interact directly. For the initial approach to this question, we used an overlay protocol, which is commonly used to determine if a protein can interact with proteins on a solid matrix (Sojar et al., 2002) . Purified preparations of PRN, FHA, PTX, bovine serum albumin (BSA) and DN549 (AC toxin mutant lacking the N-terminal 549 amino acids) were subjected to SDS-PAGE, transferred to nitrocellulose membranes, and then overlaid with purified wild-type AC toxin. Binding of AC toxin to proteins on the nitrocellulose membrane was visualized using a monoclonal antibody (mAb), 3D1, directed against amino acids 373-399 of AC toxin.
As shown in Fig. 3 , AC toxin bound to DN549, supporting the finding that AC toxin can associate with itself in solution (S. J. Lee, M.C. Gray and E.L. Hewlett, manuscript in preparation) and that the first 549 amino acids of AC toxin are not necessary for this interaction. AC toxin did not interact with PRN or PTX on the nitrocellulose membrane, consistent with the earlier observation that these virulence determinants had no effect on AC toxin distribution in B. pertussis. Most importantly, AC toxin bound to FHA on the nitrocellulose membrane, suggesting that a direct physical interaction occurs between AC toxin and FHA (Fig. 3) . On control blots, containing full-length AC toxin as a positive control, mAb 3D1 did not bind to DN549 or FHA in the absence of the AC toxin overlay (data not shown).
To determine if AC toxin and FHA interact in solution, purified AC toxin and FHA were incubated together, then immunoprecipitated with 9D4 (a mAb against the repeat region of AC toxin) bound to protein G beads. Proteins were eluted from the mAb-coated beads using Laemmli buffer, subjected to SDS-PAGE, transferred to nitrocellulose, and probed with either X3C, a mAb against FHA, or 9D4. As shown in Fig. 4 , FHA was immunoprecipitated as a complex with AC toxin, as FHA was eluted from 9D4-coated beads only when AC toxin was present. No crossreactivity of X3C with AC toxin or 9D4 with FHA was observed. These data extend the overlay results and establish that a direct physical association occurs between purified AC toxin and FHA in solution.
Conclusions and future directions
Although the general concept regarding RTX toxins has been that they are secreted into the extracellular milieu, it has been known for over 25 years that AC toxin remains primarily associated with the surface of B. pertussis. The mechanism for this interaction and its relevance to target cell intoxication has gone uninvestigated. With the recognition that another RTX toxin, leukotoxin from A. actinomycetemcomitans, is cell-associated, came an analysis of the mechanism by which that toxin interacts with the bacterial surface. Leukotoxin has been shown to bind to the bacterial surface through an interaction with nucleic acids (Ohta et al., 1993) and, more recently, a role for fibrils encoded by the tad locus in retention of leukotoxin on the surface of A. actinomycetemcomitans has been demonstrated (Kachlany et al., 2000) . Until now, leukotoxin was Fig. 3 . AC toxin interacts with filamentous haemagglutinin (FHA) on nitrocellulose blots. Purified preparations of pertactin (PRN, 1 mg), FHA (1 mg), bovine serum albumin (BSA; 1 mg), pertussis toxin (PTX; 2 mg) or DN549(10 ng) were subjected to SDS-PAGE and proteins were transferred to nitrocellulose. Blots were incubated with 5 mg ml -1 of wild-type AC toxin. Binding of AC toxin to proteins on blots was visualized by using mAb 3D1 followed by secondary HRPconjugated anti-mouse IgG and chemiluminescent detection.
the only cell-associated RTX toxin in which the mechanism of toxin interaction with the bacterial surface has been extensively studied.
In the present study, we have shown that AC toxin can interact with FHA and that the presence of FHA is important for the association of AC toxin with the B. pertussis surface. However, a small percentage of AC toxin remains associated with B. pertussis, even in the absence of FHA, thus the interaction of AC toxin with the surface of B. pertussis is likely more complicated. Current concepts concerning the structures, subcellular locations, and functions of the B. pertussis type I secretion apparatus CyaBDE are mostly based on what is known regarding the HlyBD/TolC proteins involved in E. coli haemolysin secretion (Ludwig and Goebel, 1999; Koronakis et al., 2000) . In E. coli, secretion of haemolysin is believed to be initiated by binding of the C-terminal signal sequence to HlyB and/or HlyD, subsequent binding of the periplasmic domain of HlyD to TolC, formation of a HlyD/TolC trimeric pore, then release of haemolysin to the extracellular milieu without a periplasmic intermediate (Thanabalu et al., 1998) .
CyaB and D are highly homologous to HlyB and D respectively. CyaE is proposed to perform a similar function to that of TolC, but it is the most diverged of the TolC-like protein family. Of particular interest is that the Nterminal (1-200) and C-terminal (202-419) residues of CyaE share significant sequence similarities with each other (Gross, 1995) . Although TolC does not possess this repetitive structure, its N-terminal residues (23-178) are similar to the repetitive regions of CyaE (Gross, 1995) . AC toxin is released into the medium of E. coli producing HlyBD/TolC (Sebo and Ladant, 1993) . Is it possible that the amino acid sequence differences between CyaE and TolC play a role in whether the toxin is released into the medium or remains associated with the bacterium? This is certainly one possibility that must be considered.
Like other RTX toxins that are activated by acylmodification (Hardie et al., 1991) , AC toxin is palmitoylated at lysine 983 by the product of cyaC (Barry et al., 1991; Hackett et al., 1994) . Another possibility is that the palmitoyl group plays a role in surface retention of AC toxin through an interaction with LPS. This modification alone is unlikely to represent the basis for surface retention, however, as many RTX toxins appear to be acylated (Lally et al., 1999) and most are released into the medium. Other bacteria that produce RTX toxins do not produce FHA, however, which may, in B. pertussis, interact with the palmitoyl group of AC toxin.
Finally, a role for the hydrophobic and repeat regions of AC toxin in surface retention cannot be ruled out. When expressed in E. coli, secretion of AC toxin into the medium by HlyBD/TolC is increased fourfold by deletion of at least the hydrophobic domain, with or without the repeat region, from the toxin (Sebo and Ladant, 1993) . Although it is likely that this occurs because the presence of these domains facilitates aggregation and inclusion body formation in E. coli, a role for the hydrophobic domain and repeat region in the interaction of AC toxin with the B. pertussis surface warrants further study.
Bordetella pertussis can deliver AC toxin to host cells by contact (Hewlett et al., 1988; Mouallem et al., 1990) . Preliminary studies in our laboratory suggest that live, intact bacteria intoxicate target cells more efficiently than soluble toxin isolated from the medium of FHA mutants, suggesting that the association of AC toxin with the bacterial surface induces a conformation that is much more effective for insertion of the catalytic domain into the target cell membrane. The interaction of AC toxin with FHA may help to increase the local concentration of AC toxin on the B. pertussis outer membrane and adherence to host cells mediated by FHA may be coupled to AC toxin delivery. These concepts, derived from demonstration of the direct interaction of AC toxin with FHA, are serving as the basis for current studies of AC toxin delivery from B. pertussis to target cells.
Experimental procedures
Growth of B. pertussis strains
All B. pertussis strains were cultured on Bordet-Genou agar (Gibco) containing 20% defibrinated sheep blood (Cocalico) or in Stainer-Scholte broth (Gibco) (Hewlett et al., 1989) with the appropriate antibiotics at the following concentrations: nalidixic acid, 30 mg ml ; and streptomycin, 100 mg ml . Antibiotics and all other chemicals, Fig. 4 . FHA co-precipitates with AC toxin on beads coated with anti-AC toxin antibody. AC toxin alone (ACT; 4.4 mg), FHA alone (FHA; 4.4 mg), or AC toxin and FHA (ACT/FHA; 4.4 mg each) were incubated for 2 h at 4∞C. Proteins were immunoprecipitated with beads coated with 9D4, a monoclonal antibody against AC toxin. Samples eluted from beads were subjected to SDS-PAGE and transferred to nitrocellulose. The presence of FHA in ACT-FHA complexes was detected using the monoclonal anti-FHA antibody, X3C; FHA was not immunoprecipitated by 9D4-coated beads in the absence of ACT. AC toxin was detected by probing blots with 9D4; as expected, AC toxin bound to beads. Antibody binding to nitrocellulose was detected by chemiluminescence.
unless otherwise stated, were obtained from Sigma. Bacteria on plates were grown at 37∞C for 3-5 days then subcultured to 12 mls of broth at 35.5∞C for 24 h. Bacteria were then subcultured into 50-200 mls of broth and grown for an additional 24 h before experimentation.
The B. pertussis strains used in this study are listed in Table 1 
Immunoblotting
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed as described by Laemmli (Laemmli, 1970) using 10% PA gels (Bio-Rad). Proteins were transferred to nitrocellulose membranes (Osmonics) at 100 V for 1 h in 20 mM Tris, 150 mM glycine, 20% methanol, blocked overnight at 4∞C with 5% skimmed milk in TBS (50 mM Tris pH 7.5, 200 mM NaCl), and probed for 1-2 h at room temperature (RT) with either a rabbit polyclonal antibody (1:1000 dilution) or mouse monoclonal antibodies (mAbs), 3D1 (1:15 000 dilution) or 9D4 (1:1000 dilution), against AC toxin (Lee et al., 1999) . AC toxin is proteolytically sensitive, thus several high molecular weight bands are often visualized by immunoblot analysis. FHA was detected on membranes using mAb X3C (provided by Dr Drusilla Burns). All antibodies were diluted into TBS plus 5% skimmed milk. Membranes were washed three times (5-15 min each) in TBS plus 0.1% Tween 20 (TBS-T) and were incubated for 30 min to 1 h at RT in anti-rabbit or anti-mouse immunoglobulin G secondary antibody conjugated to horseradish peroxidase (HRP; 1:1000 dilution) (Jackson ImmunoResearch Laboratories). After three more washes with TBS-T, ECL Western blotting detection reagents (Amersham-Pharmacia Biotech) were added to the membranes and the bands were visualized by chemiluminescence.
Isolation and treatment of B. pertussis crude outer membranes
Crude outer membranes of B. pertussis strain BP338 were isolated by the protocol initially described by Schneider and co-workers (Schneider and Parker, 1982) and subsequently modified by Johnson and Burns (Johnson and Burns, 1994) . Briefly, exponentially growing B. pertussis were harvested using centrifugation at 6000 r.p.m. for 10 min, washed once in phosphate-buffered saline (pH 7.5; PBS), and the bacterial pellet was resuspended in PBS and frozen at -70∞C. The pellet was thawed in cold water and the bacteria were sonicated (Model W-375; Heat Systems Ultrasonics) on power setting '3' and 50% duty cycle for 5 min on ice three times with 1 min between cycles. Unbroken cells were removed by centrifugation at 2000 g for 10 min and the supernate was subjected to ultracentrifugation at 107 000 g for 1 h to pellet the total (inner and outer) membrane fraction.
To solubilize the inner membrane, total membranes were suspended in 50 mM N-2-hydroxyethylpiperazine-N¢-2ethanesulfonic acid (Hepes) buffer, pH 7.4, containing 2% Triton X-100 and 7.5 mM MgCl 2 , and were incubated on a vertically rotating wheel overnight at 4∞C. The membranes were centrifuged again at 107 000 g for 1 h to pellet the insoluble fraction (crude outer membranes) and the presence of AC toxin in the outer membrane fraction was confirmed by immunoblot analysis using rabbit polyclonal anti-AC toxin antibody.
Crude outer membranes (80 mg) were incubated in either TEE (Tricine 10 mM, EDTA 0.5 mM, EGTA 0.5 mM-pH 8.0), 8 M urea-TEE, 10 mM octylglucoside/150 mM NaCl (pH 7.3), or 100 mM sodium carbonate (pH 11.5) overnight at 4∞C and the membranes were centrifuged 107 000 g for 1 h. The supernate, representing the soluble fraction was removed and the pellet, representing the insoluble fraction, was resuspended in PBS to an equal volume as the soluble fraction. Equal volumes of the soluble and insoluble material were subjected to SDS-PAGE, the proteins were transferred to nitrocellulose, and the presence of AC toxin was determined by immuno-blotting with anti-AC toxin polyclonal antibody. Interestingly, whereas urea extracted AC toxin from crude outer membrane preparations, it did not extract other outer membrane proteins, such as FHA. Octylglucoside and carbonate, however, did release FHA into the soluble fraction.
Because the inner and outer membranes of B. pertussis cannot be separated by isopycnic centrifugation (Ezzel et al., 1981) , Triton X-100 is commonly used to differentially solubilize the inner membrane proteins. The procedure used here to isolate crude B. pertussis outer membranes has been used, with some modifications, to demonstrate the outer membrane localization of the S1 subunit of PTX (Farizo et al., 2002) and proteins responsible for PTX secretion (PtlF and PtlG) (Johnson and Burns, 1994) in B. pertussis.
Distribution of AC toxin or FHA in mutant B. pertussis
Strains were cultured as described above. When the OD 650 reached between 0.7 and 1.0, cultures were centrifuged at 6000 r.p.m. for 10 min and the supernate was removed and frozen at -70∞C for later determination of AC enzymatic activity. The resultant pellet was washed once with Hanks Balanced Salt Solution (HBSS; Gibco), centrifuged as above, resuspended in HBSS to the original volume, and frozen at -70∞C. AC enzymatic activity in supernate and pellet fractions was determined as described previously (Hewlett et al., 1989) . The percentage of AC toxin associated with the bacterial pellet was determined by dividing the AC enzymatic activity in the bacterial pellet by the total AC enzymatic activity (supernate plus bacterial pellet) multiplied by 100. Results are representative of at least two independent experiments. Student's t-test was used to compare the percentage of bac-teria-associated AC activity between wild-type and mutant strains.
Binding of exogenous AC toxin to B. pertussis
Bordetella pertussis organisms were grown to an OD 650 of between 0.7 and 1.0. Bacteria were centrifuged at 6000 r.p.m. for 10 min, washed once in HBSS, and resuspended in HBSS to the starting volume to yield approximately 10 9 bacteria per ml. Then, 10 mg ml -1 of AC toxin was added to 10 9 bacteria and incubated for 1 h at RT. Bacteria were centrifuged at 10 000 r.p.m. in a microfuge for 5 min, washed three times with 1 ml of HBSS, and resuspended in 1 ml of HBSS. Samples were frozen at -70∞C for determination of AC enzymatic activity. The percentage of exogenous AC toxin that bound to whole bacteria was determined by the following equation:
Overlay
To determine if AC toxin can interact with proteins on a solid matrix, we subjected purified PRN, FHA, BSA (1 mg each), PTX (2 mg), and DN549 (AC toxin truncate lacking the first 549 amino acids of AC toxin; 10 ng) to SDS-PAGE on 10% PA gels. Purified PRN, FHA and PTX were provided by Carine Capiau (GlaxoSmithKline). Proteins were transferred to nitrocellulose and membranes were incubated with 5 mg ml -1 of full-length AC toxin in TBS-T plus 5% skimmed milk for 2 h at RT. After three washes in TBS-T for 15 min each, the membranes were subjected to immunoblot analysis as described earlier, using mAb 3D1, which recognizes wildtype AC toxin, but not DN549.
Immunoprecipitation
To determine if AC toxin and FHA interact in solution, AC toxin, FHA, and AC toxin + FHA were mixed end-over-end at 4∞C for 2 h. AC toxin was then immunoprecipitated from these samples using mAb 9D4 bound to protein GSepharose (Gammabind G Sepharose, Pharmacia) as described (Bonifacino et al., 2001) . Briefly, 30 ml of 50% protein G-Sepharose bead slurry was combined with 1 mg of mAb 9D4 and mixed end-over-end for 2 h at 4∞C. Antibodycoated beads were washed three times in 50 mM Tris-HCl, pH 7.4, 300 mM NaCl, 5 mM EDTA, 1% Triton X-100. Then, 10 ml of 10% BSA was added to the mAb-coated bead pellet along with 1 ml of PBS containing either 4.4 mg of AC toxin, 4.4 mg of FHA or 4.4 mg of both AC toxin and FHA, which had been incubated for 2h at 4∞C. This protein/antibody-coated bead mixture was then incubated for 1 h at 4∞C mixing end over end. Beads were washed four times with 50 mM TrisHCl, pH 7.4, 300 mM NaCl, 5 mM EDTA, 0.1% Triton X-100 and once with PBS, pH 7.4. Proteins were eluted from the beads with Laemmli buffer, subjected to SDS-PAGE on 10% PA gels, and transferred to nitrocellulose membranes. The total AC enzymatic activity exogenous endogenous endogenous AC activity AC activity added to bacteria
] ¥ 100 membranes were probed either with mAb 9D4 (for detection of AC toxin) or mAb X3C (for detection of FHA).
